TELAVANCIN HYDROCHLORIDE
Substance profile for UNII 0701472ZG0, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- 0701472ZG0
- Preferred term
- TELAVANCIN HYDROCHLORIDE
- Registry number
- 560130-42-9
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C80H106Cl2N11O27P.ClH
Chemical And Database Identifiers#
- InChIKey
- GSSIWSIRBWAZHG-ACOPVEIWSA-N
- SMILES
- Cl.CCCCCCCCCCNCCN[C@@]1(C)C[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2OC3=C4OC5=CC=C(C=C5Cl)[C@@H](O)[C@@H]6NC(=O)[C@H](NC(=O)[C@@H]7NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](NC(=O)[C@@H](CC(C)C)NC)[C@H](O)C8=CC(Cl)=C(OC3=CC7=C4)C=C8)C9=CC(=C(O)C=C9)C%10=C(O)C(CNCP(O)(O)=O)=C(O)C=C%10[C@H](NC6=O)C(O)=O)O
- RxCUI
- 864624
- PubChem
- 9812715
- NCIt
- C87636
- INN ID
- 0
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| PubChem Compound | 9812715 | https://pubchem.ncbi.nlm.nih.gov/compound/9812715 |
| PubChem InChIKey Search | GSSIWSIRBWAZHG-ACOPVEIWSA-N | https://pubchem.ncbi.nlm.nih.gov/#query=GSSIWSIRBWAZHG-ACOPVEIWSA-N |
| RxNorm | 864624 | https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=864624 |
| NCI Thesaurus | C87636 | https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C87636 |
| FDA Substance Registration System | 0701472ZG0 | https://precision.fda.gov/uniisearch/srs/unii/0701472ZG0 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| telavancin hydrochloride | ACTIVE INGREDIENT | 0701472ZG0 | These highlights do not include all the information needed to use VIBATIV ® (telavancin) safely and effectively. See full prescribing information for VIBATIV. VIBATIV ® (telavancin) for injection, for intravenous use Initial U.S. Approval: 2009 | 9 | |
| telavancin hydrochloride | ACTIVE INGREDIENT | 0701472ZG0 | VIBATIV (TELAVANCIN HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [THERAVANCE BIOPHARMA ANTIBIOTICS, INC.] | 3 |